Patients with chronic bowel disease are increasingly finding it difficult to get their much-needed medicines. Firms stop making medication because it would no longer be profitable for the Belgian market. The pharmaceutical agency FAMHP has started an investigation into the inadequate supply of at least one much more expensive drug.

Powered by the Echo RSS Plugin by CodeRevolution.